ID MIL1_YEAST Reviewed; 1073 AA. AC P43564; D6VTJ7; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 21-SEP-2011, sequence version 2. DT 02-SEP-2026, entry version 174. DE RecName: Full=Probable lipase MIL1 {ECO:0000303|PubMed:26658609}; DE EC=3.1.1.- {ECO:0000305|PubMed:26658609}; DE AltName: Full=Medium adaptin-interacting ligand 1 {ECO:0000303|PubMed:26658609}; GN Name=MIL1 {ECO:0000303|PubMed:26658609}; OrderedLocusNames=YFL034W; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=7670463; DOI=10.1038/ng0795-261; RA Murakami Y., Naitou M., Hagiwara H., Shibata T., Ozawa M., Sasanuma S., RA Sasanuma M., Tsuchiya Y., Soeda E., Yokoyama K., Yamazaki M., Tashiro H., RA Eki T.; RT "Analysis of the nucleotide sequence of chromosome VI from Saccharomyces RT cerevisiae."; RL Nat. Genet. 10:261-268(1995). RN [2] RP GENOME REANNOTATION, AND SEQUENCE REVISION TO 323. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [3] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [4] RP INTERACTION WITH RPP0. RX PubMed=15286401; DOI=10.1007/bf02702559; RA Aruna K., Chakraborty T., Nambeesan S., Mannan A.B., Sehgal A., RA Balachandara S.R., Sharma S.; RT "Identification of a hypothetical membrane protein interactor of ribosomal RT phosphoprotein P0."; RL J. Biosci. 29:33-43(2004). RN [5] RP TOPOLOGY [LARGE SCALE ANALYSIS]. RC STRAIN=ATCC 208353 / W303-1A; RX PubMed=16847258; DOI=10.1073/pnas.0604075103; RA Kim H., Melen K., Oesterberg M., von Heijne G.; RT "A global topology map of the Saccharomyces cerevisiae membrane proteome."; RL Proc. Natl. Acad. Sci. U.S.A. 103:11142-11147(2006). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ADR376; RX PubMed=17330950; DOI=10.1021/pr060559j; RA Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., RA Elias J.E., Gygi S.P.; RT "Large-scale phosphorylation analysis of alpha-factor-arrested RT Saccharomyces cerevisiae."; RL J. Proteome Res. 6:1190-1197(2007). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1037, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19779198; DOI=10.1126/science.1172867; RA Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.; RT "Global analysis of Cdk1 substrate phosphorylation sites provides insights RT into evolution."; RL Science 325:1682-1686(2009). RN [9] RP FUNCTION, INTERACTION WITH APM2, DOMAIN, AND MUTAGENESIS OF RP 143-TRP--PRO-147; SER-759; ASP-817 AND HIS-858. RX PubMed=26658609; DOI=10.1091/mbc.e15-09-0621; RA Whitfield S.T., Burston H.E., Bean B.D., Raghuram N., Maldonado-Baez L., RA Davey M., Wendland B., Conibear E.; RT "The alternate AP-1 adaptor subunit Apm2 interacts with the Mil1 regulatory RT protein and confers differential cargo sorting."; RL Mol. Biol. Cell 27:588-598(2016). CC -!- FUNCTION: Probable lipase that recruits the AP-1-related (AP-1R) CC complex to membranes via interaction with APM2 (PubMed:26658609). The CC AP-1R complex is an adapter protein complex that mediates of cargo CC protein SNC1 sorting in clathrin-coated vesicles (PubMed:26658609). CC {ECO:0000269|PubMed:26658609}. CC -!- SUBUNIT: Interacts with RPP0 (PubMed:15286401). Interacts with APM2 CC (PubMed:26658609). {ECO:0000269|PubMed:15286401, CC ECO:0000269|PubMed:26658609}. CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane CC {ECO:0000269|PubMed:26658609}; Multi-pass membrane protein CC {ECO:0000255}. Early endosome membrane {ECO:0000269|PubMed:26658609}; CC Multi-pass membrane protein {ECO:0000255}. Cytoplasmic vesicle, CC clathrin-coated vesicle membrane {ECO:0000269|PubMed:26658609}; Multi- CC pass membrane protein {ECO:0000255}. CC -!- MISCELLANEOUS: Present with 1110 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the TMCO4 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D50617; BAA09205.1; -; Genomic_DNA. DR EMBL; BK006940; DAA12407.2; -; Genomic_DNA. DR PIR; S56220; S56220. DR RefSeq; NP_116583.2; NM_001179932.2. DR AlphaFoldDB; P43564; -. DR BioGRID; 31113; 87. DR DIP; DIP-6508N; -. DR FunCoup; P43564; 115. DR IntAct; P43564; 8. DR MINT; P43564; -. DR STRING; 4932.YFL034W; -. DR ESTHER; yeast-yfd4; Duf_726. DR GlyCosmos; P43564; 8 sites, No reported glycans. DR GlyGen; P43564; 8 sites. DR iPTMnet; P43564; -. DR PaxDb; 4932-YFL034W; -. DR PeptideAtlas; P43564; -. DR EnsemblFungi; YFL034W_mRNA; YFL034W; YFL034W. DR GeneID; 850510; -. DR KEGG; sce:YFL034W; -. DR AGR; SGD:S000001860; -. DR SGD; S000001860; MIL1. DR VEuPathDB; FungiDB:YFL034W; -. DR eggNOG; KOG2385; Eukaryota. DR HOGENOM; CLU_001695_2_1_1; -. DR InParanoid; P43564; -. DR OMA; KEVGWEV; -. DR OrthoDB; 277931at2759; -. DR BioCyc; YEAST:G3O-30428-MONOMER; -. DR BioGRID-ORCS; 850510; 0 hits in 10 CRISPR screens. DR PRO; PR:P43564; -. DR Proteomes; UP000002311; Chromosome VI. DR RNAct; P43564; protein. DR GO; GO:0030665; C:clathrin-coated vesicle membrane; IEA:UniProtKB-SubCell. DR GO; GO:0031901; C:early endosome membrane; EXP:UniProtKB. DR GO; GO:0000139; C:Golgi membrane; EXP:UniProtKB. DR GO; GO:0016020; C:membrane; IDA:SGD. DR GO; GO:0035650; F:AP-1 adaptor complex binding; IDA:SGD. DR GO; GO:0035652; P:clathrin-coated vesicle cargo loading; IMP:SGD. DR InterPro; IPR029058; AB_hydrolase_fold. DR InterPro; IPR007941; DUF726. DR PANTHER; PTHR17920:SF3; TRANSMEMBRANE AND COILED-COIL DOMAIN-CONTAINING PROTEIN 4; 1. DR PANTHER; PTHR17920; TRANSMEMBRANE AND COILED-COIL DOMAIN-CONTAINING PROTEIN 4 TMCO4; 1. DR Pfam; PF05277; DUF726; 1. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. PE 1: Evidence at protein level; KW Cytoplasmic vesicle; Endosome; Glycoprotein; Golgi apparatus; Hydrolase; KW Membrane; Phosphoprotein; Reference proteome; Transmembrane; KW Transmembrane helix. FT CHAIN 1..1073 FT /note="Probable lipase MIL1" FT /id="PRO_0000202674" FT TRANSMEM 292..312 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 457..477 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 553..573 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 577..597 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 818..838 FT /note="Helical" FT /evidence="ECO:0000255" FT REGION 1..151 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 163..190 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 230..267 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 385..448 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 942..968 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1010..1073 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 143..147 FT /note="APM2-interacting WQEMP motif" FT /evidence="ECO:0000269|PubMed:26658609" FT COMPBIAS 54..81 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 101..121 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 233..249 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 252..267 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 404..427 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1027..1037 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 435 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:19779198" FT MOD_RES 1037 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT CARBOHYD 190 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 229 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 236 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 280 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 411 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 495 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 726 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT CARBOHYD 850 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498" FT MUTAGEN 143..147 FT /note="WQEMP->AAEAA: Impairs the interaction with APM2 and FT its recruitment to membranes, and leads to sertraline FT sensitivity." FT /evidence="ECO:0000269|PubMed:26658609" FT MUTAGEN 759 FT /note="S->A: Increases sensitivity to sertraline." FT /evidence="ECO:0000269|PubMed:26658609" FT MUTAGEN 817 FT /note="D->A: Increases sensitivity to sertraline." FT /evidence="ECO:0000269|PubMed:26658609" FT MUTAGEN 858 FT /note="H->A: Increases sensitivity to sertraline." FT /evidence="ECO:0000269|PubMed:26658609" FT CONFLICT 323 FT /note="K -> N (in Ref. 1; BAA09205)" FT /evidence="ECO:0000305" SQ SEQUENCE 1073 AA; 119510 MW; 2CB2CAB4F9E24DA2 CRC64; MSDSEEDLGV QLKGLKIARH LKESGEHTDE ESNSSPEHDC GLSNQDDLTV MHTQAKEEVF KRREEDGTRT EDALHEGEAG KEGTGFPSSQ SVCSPNEADS GIDRADKPIL LDPFKSVHDT DPVPGTKSRS NSDSDSDSDD GGWQEMPAVS SFNIYNHRGE LELTSKVRNS EQASETSPTV PPGKNCKSVN DSRFDYTKMA AEQQAQRSYR TNKKTDFLFD HKVLKKKINS SQTSVNLTSS PSTTSLNNEK NNDDDDDDSY DEYEDDVEPV NDLNRDSQLN ITKNLLSDME KFAYVGAINI LANQMCTNLA TLCLCIDIKS HKKLAHRLQF TQKDMAAWKT VVLSRLYDHL GISQEEIVMI EKLSLHKIQL EDLCKCLKTT QSIDNPWEND RDHEEDGIEE TTERMSPNEQ NGSVQASTPD PEQSATPETP KAKQSPLSSD VPGKVLDPEN VKSQDKLNID VAWTIICDLF LICLQSSTYD SRSRTLLINF AKVLNMTSLE ICEFERRVTD SLDMEQSTED QVWDEQDHMR NRRRSKRRKK MAYVALAMVG GSLVLGLSGG LLAPVIGGGI AAGLSTIGIT GATSFLTGVG GTTVVAVSST AIGANIGARG MSKRMGSVRT FEFRPLHNNR RVNLILTVSG WMVGNEDDVR LPFSTVDPVE GDLYSLYWEP EMLKSIGQTV SIVATEIFTT SLQQILGATV LTALISSIQW PMALSKLGYI LDNPWNVSLD RAWSAGKILA DTLIARNLGA RPITLVGFSI GARVIFSCLI ELCKKKALGL IENVYLFGTP AVMKKEQLVM ARSVVSGRFV NGYSDKDWFL AYLFRAAAGG FSAVMGISTI ENVEGIENIN CTEFVDGHLN YRKSMPKLLK RIGIAVLSEE FVEIEEMMNP EEVKRKRKLI NDVDAAQKKL SERKKHNSWV PKWLKPKKSK WKVMVEEAVE EGRDMQDLPE NDVNNNENEN PDEHEGIARQ KRRDAALVDH GALMHELQLI KQAMHEDEIK NKACLPGEDK EVESSNDFLG ESHYKPPSTP KINPPQSPNN FQLLSAGRTI LPEDDDFDPR GKKKVEFSFP DDI //